This method accounts for approximately 38.6% of the market in 2025 and is preferred by generic manufacturers for its lower capital requirements, shorter lead times, and well-defined impurity profiles that facilitate regulatory comparability studies
From the initial consultation to ongoing monitoring and adjustments, the clinic is with its patients every step of the way, ensuring that every treatment plan is optimized for success
It offers proven, multifaceted benefits backed by decades of research, excellent safety profiles, and sustainable results
Beyond its use in type 2 diabetes under the brand name Victoza, liraglutide is also available as Saxenda, a higher-dose formulation approved for weight management in adults with obesity or overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia